Research Article

Related GMR Articles

11/19/2015
FTO gene; Kazakh; Metabolic syndrome; Polymorphisms

The aim of this study was to assess the association between three FTO polymorphisms (rs9939609, rs8057044, and rs1421085) and metabolic syndrome (MS)-related outcomes in the low-income, rural, nomadic minority Khazakh population in far western China. A total of 489 subjects (245 MS patients, 244 controls) were included in the study and DNA samples were genotyped for the three ... more

Y.H. Hu; J.M. Liu; M. Zhang; R.L. Ma; H. Guo; K. Wang; J. He; Y.Z. Yan; D.S. Rui; F. Sun; L.T. Mu; Q. Niu; Y.S. Ding; J.Y. Zhang; S.G. Li; S.X. Guo
10/30/2015
Duodenal ulcer; Helicobacter pylori; Macrophage migration-inhibitory factor (MIF); MIF expression

The aim of this study was to examine the expression of macrophage migration-inhibitory factor (MIF) in duodenal ulcer epithelial cells and its relation to Helicobacter pylori (Hp) infection, and to discuss the pathogenic roles of MIF expression and Hp infection in duodenal ulcer. MIF protein and mRNA expression was examined in samples from patients with duodenal ulcer with and ... more

X.H. Yu; Q. Zhang; X.P. Yang; W. Yang; F. Dai; Z. Qian; Z.L. Wang; C.F. Wu; H.Z. Zhao; G.H. Wang
09/02/2016
frxA gene; Helicobacter pylori; MAS-PCR; Metronidazole; rdxA gene

Resistance to metronidazole (Mtz) in Helicobacter pylori is a major problem worldwide, especially in developing countries. Alterations in Mtz nitroreductase enzymes, such as oxygen-insensitive NADPH nitroreductase (RdxA) and NADPH flavin oxidoreductase (FrxA), are the major contributing factors for this resistance. In this study, rdxA and frxA were amplified, ... more

T.R.P. Butlop; N.T.N. Mungkote; N.T.R. Chaichanawongsaroj; T.R.P. Butlop; N.T.N. Mungkote; N.T.R. Chaichanawongsaroj
10/24/2016
Bacterial killing; CD209a; Helicobacter pylori; LECT2; Macrophages; NF-κB

Helicobacter pylori employs unique methods to colonize the stomach, which induces chronic inflammation. It is also able to avoid eradication by macrophages and other immune cells. Leukocyte cell-derived chemotaxin 2 (LECT2), a multi-functional cytokine involved in many pathological conditions, has recently been shown to activate macrophages via the CD209a ... more

H.X. Shen; L. Li; Q. Chen; Y.Q. He; C.H. Yu; C.Q. Chu; X.J. Lu; J. Chen
08/14/2015
Diabetes mellitus; experimental; MicroRNA profiling; Skin; Wound healing

Despite years of effort, current therapies for diabetic wounds are still not fully efficacious. Emerging evidence has suggested that microRNAs (miRNAs) play key roles in multiple physiological and pathological processes in eukaryotes, and could potentially be powerful therapeutic tools. This study investigated the differential expression profiling of miRNAs in cutaneous wounds in ... more

Y.F. Liu; M. Ding; D.W. Liu; Y. Liu; Y.G. Mao; Y. Peng
08/03/2015
Diabetes mellitus; Genetic susceptibility; Melatonin receptor; MT2; Pregnancy; Single nucleotide polymorphisms

We investigated the association between rs4753426 single nucleotide polymorphisms in the melatonin receptor 1B (MTNR1B) gene and the risk of developing gestational diabetes mellitus (GDM). A total of 516 gravidas (186 with GDM and 330 non-diabetic controls) were enrolled in the study. Genotype and allele frequencies of rs4753426 in the MTNR1B gene were detected by DNA ... more

Y. Zhan; C. Li; Q. Gao; J. Chen; S. Yu; S.G. Liu
07/31/2015
ABCG5; Cholesterol efflux; CYP7A1; Diabetes mellitus; LXRβ; Monocyte macrophage

The purpose of this study was to examine the changes of cellular cholesterol efflux from macrophages in patients with type II diabetes mellitus (DM), and to determine the expression of CYP7A1, ABCG5, and LXRβ therein. We recruited 30 patients with type II DM (including 15 patients complicated with coronary heart disease and 15 patients with DM only) and 15 normal controls for this study ... more

L.D. Bao; C.Q. Li; R. Peng; X.H. Ren; R.L. Ma; Y. Wang; H.J. Lv
07/14/2016
Breast cancer; Diabetes mellitus; miR-221/222

The aim of the research was to examine the expression level of microRNA221/222 (miR-221/222) in the serum of patients with type 2 diabetes mellitus (T2DM) who are also diagnosed with post-menopausal breast cancer. We aimed to evaluate the differences in microRNA expression in patients with T2DM alone, patients with post-menopausal breast cancer alone, and patients with both T2DM and post ... more

M.Y. Li; S.R. Pan; A.Y. Qiu; M.Y. Li; S.R. Pan; A.Y. Qiu
08/17/2017
Alcohol Drinking; Atherosclerosis; Case-control studies; Diabetes mellitus; Humans; Polymorphism, Single Nucleotide; Smoking; Tumor Suppressor Protein p53

Atherosclerosis is a multifactorial pathological disease that alters the morphology and function of arterial walls. The atheroma growth leads to vessel hardening and lumen narrowing, limiting the blood flow. The atheroma plaque can eventually break, expose highly thrombogenic material and lead to platelet activation and subsequent formation of a thrombus that may block blood flow in loco, or ... more

M.H. Lagares; K.S.F. Silva; A.M. Barbosa; D.A. Rodrigues; I.R. Costa; J.V.M. Martins; M.P. Morais; F.L. Campedelli; K.K.V.O. Moura
03/25/2021
Chronic inflammation; CVD; Diabetes mellitus; Hs-CRP; Lipid profile

Diabetes mellitus (DM) continues to be the epidemic of the century and has a major impact on mortality from all causes and from cardiovascular disease (CVD). The systemic inflammatory pathway provides the common pathogenetic link in this comorbidity. We examined serum high- sensitivity C-reactive protein (hs-CRP) levels, as a marker of systemic inflammation in ... more

T.D. Cam; T.A. Hoang; H.T. Le; H.V. Quyet; P.T. Trung; N.T. Binh; V.T.M. Thuc

Pages